SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 157 filers reported holding SERES THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,385 | -40.7% | 53,943 | +19.3% | 0.00% | – |
| Q2 2023 | $216,532 | +2.7% | 45,205 | +21.5% | 0.00% | – |
| Q1 2023 | $210,878 | -9.6% | 37,192 | -10.7% | 0.00% | – |
| Q4 2022 | $233,256 | +74.1% | 41,653 | +99.5% | 0.00% | – |
| Q3 2022 | $134,000 | +83.6% | 20,882 | -1.7% | 0.00% | – |
| Q2 2022 | $73,000 | -55.5% | 21,243 | -7.9% | 0.00% | – |
| Q1 2022 | $164,000 | -13.2% | 23,057 | +1.4% | 0.00% | – |
| Q4 2021 | $189,000 | -17.8% | 22,742 | -31.4% | 0.00% | – |
| Q3 2021 | $230,000 | -83.2% | 33,140 | -42.4% | 0.00% | -100.0% |
| Q2 2021 | $1,371,000 | +13.6% | 57,519 | -1.8% | 0.00% | 0.0% |
| Q1 2021 | $1,207,000 | +51.8% | 58,583 | +80.7% | 0.00% | 0.0% |
| Q4 2020 | $795,000 | +250.2% | 32,424 | +304.7% | 0.00% | – |
| Q3 2020 | $227,000 | – | 8,012 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |